Xilio Therapeutics Taps Ex-Blueprint Medicines Atty As GC
Biotechnology company Xilio Therapeutics Inc. announced Monday that it has tapped Blueprint Medicines Corp.'s vice president of corporate legal affairs as its new general counsel....To view the full article, register now.
Already a subscriber? Click here to view full article